| Product Code: ETC13281111 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Extracorporeal Membrane Oxygenation ECMO Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 2.4 Billion by 2031, growing at a compound annual growth rate of 7.90% during the forecast period (2025-2031).
The Global Extracorporeal Membrane Oxygenation (ECMO) Market is experiencing significant growth driven by the rising prevalence of respiratory and cardiac diseases, advancements in technology, and increasing awareness about ECMO therapy. ECMO is a life-saving technique that provides temporary support for patients with severe heart or lung failure, allowing the organs to rest and recover. The market is characterized by the presence of key players offering a variety of ECMO systems, including portable and stationary devices, oxygenators, pumps, and cannulas. North America leads the market due to high healthcare expenditure and a well-established healthcare infrastructure, while the Asia Pacific region is expected to witness rapid growth due to the increasing adoption of ECMO therapy in countries like China and India. Overall, the Global ECMO Market is projected to continue expanding as the demand for advanced life support systems rises globally.
The Global Extracorporeal Membrane Oxygenation (ECMO) Market is experiencing significant growth driven by the increasing prevalence of respiratory and cardiac diseases, advancements in technology, and rising demand for ECMO therapy in intensive care units. Key trends include the development of portable and miniaturized ECMO devices, expanding applications beyond traditional cardiac and respiratory support, and the adoption of ECMO in pediatric and neonatal care. Opportunities in the market lie in the growing number of ECMO centers, rising healthcare expenditure in emerging economies, and collaborations between healthcare providers and ECMO device manufacturers to improve patient outcomes. Additionally, the increasing awareness about ECMO therapy among healthcare professionals and patients is expected to further drive market growth in the coming years.
The Global Extracorporeal Membrane Oxygenation (ECMO) Market faces several challenges, including high costs associated with ECMO procedures and equipment, limited availability of specialized healthcare professionals trained in ECMO technology, and the risk of complications such as bleeding, infections, and organ failure during ECMO treatment. Additionally, there are challenges related to the lack of standardized protocols for ECMO use, varying reimbursement policies across different regions, and the need for continuous technological advancements to improve ECMO efficacy and safety. Market competition among ECMO device manufacturers and the regulatory hurdles for obtaining approvals for new ECMO products further add complexity to the market landscape. Addressing these challenges will be crucial for the sustainable growth and advancement of the Global ECMO Market.
The Global Extracorporeal Membrane Oxygenation (ECMO) Market is primarily driven by the increasing prevalence of respiratory and cardiac diseases, rising demand for advanced life support technologies, and growing awareness about ECMO therapy among healthcare professionals and patients. Additionally, technological advancements in ECMO devices, such as improved portability, enhanced efficiency, and reduced complications, are fueling market growth. The expanding applications of ECMO in treating severe respiratory failure, cardiac failure, and other life-threatening conditions are also contributing to the market`s expansion. Moreover, the growing investment in healthcare infrastructure, especially in developing regions, and the rising number of ECMO centers worldwide are propelling the market forward. Overall, the increasing adoption of ECMO therapy as a life-saving intervention and the continuous research and development efforts in this field are key factors driving the growth of the Global ECMO Market.
Government policies related to the Global Extracorporeal Membrane Oxygenation (ECMO) Market primarily focus on ensuring patient safety, regulating device approval processes, and promoting innovation in the healthcare sector. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the EU play a crucial role in overseeing the approval and monitoring of ECMO devices to guarantee their efficacy and safety. These policies aim to standardize the quality of ECMO technology, streamline market access for manufacturers, and ultimately improve patient outcomes. Additionally, government initiatives may also include funding research and development projects to advance ECMO technology and address healthcare challenges effectively. Overall, government policies in the ECMO market prioritize patient care, device safety, and technological advancements to enhance healthcare delivery globally.
The Global Extracorporeal Membrane Oxygenation (ECMO) market is expected to witness significant growth in the coming years, driven by the rising prevalence of respiratory and cardiac diseases, advancements in ECMO technology, and the increasing adoption of ECMO in critical care settings. The market is projected to expand further due to the growing number of ECMO centers worldwide, improving healthcare infrastructure in developing countries, and the rising awareness about the benefits of ECMO in treating severe respiratory or cardiac failure. Additionally, the increasing investment in research and development activities focused on enhancing ECMO devices and techniques is expected to propel market growth. However, cost constraints and the complexity of ECMO procedures may hinder market growth to some extent, necessitating ongoing efforts to address these challenges and improve patient outcomes.
In the Global Extracorporeal Membrane Oxygenation (ECMO) market, Asia is expected to witness significant growth due to the rising prevalence of respiratory and cardiac diseases in countries like China and India. North America is a mature market with a strong presence of established ECMO device manufacturers and advanced healthcare infrastructure. Europe is also a key region in the ECMO market, driven by increasing adoption of advanced medical technologies and favorable government initiatives. The Middle East and Africa region is likely to experience moderate growth, supported by improving healthcare facilities and rising awareness about ECMO therapy. Latin America is anticipated to show steady growth, attributed to the increasing healthcare expenditure and growing demand for ECMO treatment options in countries like Brazil and Mexico.
Global Extracorporeal Membrane Oxygenation ECMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Extracorporeal Membrane Oxygenation ECMO Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume, 2021 & 2031F |
3.3 Global Extracorporeal Membrane Oxygenation ECMO Market - Industry Life Cycle |
3.4 Global Extracorporeal Membrane Oxygenation ECMO Market - Porter's Five Forces |
3.5 Global Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.7 Global Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.8 Global Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume Share, By Patient, 2021 & 2031F |
4 Global Extracorporeal Membrane Oxygenation ECMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Extracorporeal Membrane Oxygenation ECMO Market Trends |
6 Global Extracorporeal Membrane Oxygenation ECMO Market, 2021 - 2031 |
6.1 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Component, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Pumps, 2021 - 2031 |
6.1.3 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Oxygenators, 2021 - 2031 |
6.1.4 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Controllers, 2021 - 2031 |
6.1.5 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Cannula, 2021 - 2031 |
6.1.6 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Accessories, 2021 - 2031 |
6.2 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Modality, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Veno-Arterial, 2021 - 2031 |
6.2.3 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Veno-Venous, 2021 - 2031 |
6.2.4 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Arterio-Venous, 2021 - 2031 |
6.3 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Patient, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Neonates, 2021 - 2031 |
6.3.3 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
6.3.4 Global Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Adult, 2021 - 2031 |
7 North America Extracorporeal Membrane Oxygenation ECMO Market, Overview & Analysis |
7.1 North America Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume, 2021 - 2031 |
7.2 North America Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Component, 2021 - 2031 |
7.4 North America Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Modality, 2021 - 2031 |
7.5 North America Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Patient, 2021 - 2031 |
8 Latin America (LATAM) Extracorporeal Membrane Oxygenation ECMO Market, Overview & Analysis |
8.1 Latin America (LATAM) Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Component, 2021 - 2031 |
8.4 Latin America (LATAM) Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Modality, 2021 - 2031 |
8.5 Latin America (LATAM) Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Patient, 2021 - 2031 |
9 Asia Extracorporeal Membrane Oxygenation ECMO Market, Overview & Analysis |
9.1 Asia Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Component, 2021 - 2031 |
9.4 Asia Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Modality, 2021 - 2031 |
9.5 Asia Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Patient, 2021 - 2031 |
10 Africa Extracorporeal Membrane Oxygenation ECMO Market, Overview & Analysis |
10.1 Africa Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Component, 2021 - 2031 |
10.4 Africa Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Modality, 2021 - 2031 |
10.5 Africa Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Patient, 2021 - 2031 |
11 Europe Extracorporeal Membrane Oxygenation ECMO Market, Overview & Analysis |
11.1 Europe Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Component, 2021 - 2031 |
11.4 Europe Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Modality, 2021 - 2031 |
11.5 Europe Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Patient, 2021 - 2031 |
12 Middle East Extracorporeal Membrane Oxygenation ECMO Market, Overview & Analysis |
12.1 Middle East Extracorporeal Membrane Oxygenation ECMO Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Component, 2021 - 2031 |
12.4 Middle East Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Modality, 2021 - 2031 |
12.5 Middle East Extracorporeal Membrane Oxygenation ECMO Market, Revenues & Volume, By Patient, 2021 - 2031 |
13 Global Extracorporeal Membrane Oxygenation ECMO Market Key Performance Indicators |
14 Global Extracorporeal Membrane Oxygenation ECMO Market - Export/Import By Countries Assessment |
15 Global Extracorporeal Membrane Oxygenation ECMO Market - Opportunity Assessment |
15.1 Global Extracorporeal Membrane Oxygenation ECMO Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Extracorporeal Membrane Oxygenation ECMO Market Opportunity Assessment, By Component, 2021 & 2031F |
15.3 Global Extracorporeal Membrane Oxygenation ECMO Market Opportunity Assessment, By Modality, 2021 & 2031F |
15.4 Global Extracorporeal Membrane Oxygenation ECMO Market Opportunity Assessment, By Patient, 2021 & 2031F |
16 Global Extracorporeal Membrane Oxygenation ECMO Market - Competitive Landscape |
16.1 Global Extracorporeal Membrane Oxygenation ECMO Market Revenue Share, By Companies, 2024 |
16.2 Global Extracorporeal Membrane Oxygenation ECMO Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here